Literature DB >> 2508307

Lymphocyte predominant Hodgkin's disease of nodular subtype combined with pulmonary lymphoid infiltration and hypogammaglobulinaemia.

G Li1, M L Hansmann.   

Abstract

Two cases of lymphocyte predominant Hodgkin's disease of nodular subtype (HDNP) are reported. In contrast to classic cases of HDNP which often involve only one lymph node region and show no further symptoms, these two patients exhibited lymphoid infiltrates of the lung and hypogammaglobulinaemia. In patient 2 a monotypic immunoglobulin pattern (light chain kappa) was demonstrated in the L & H-, Hodgkin- and Sternberg-Reed cells. Both cases represent an uncommon variant of lymphocyte predominant Hodgkin's disease.

Entities:  

Mesh:

Year:  1989        PMID: 2508307     DOI: 10.1007/bf00747750

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  24 in total

1.  Lymphocyte predominant Hodgkin's disease nodular subtype with coexistent "large cell lymphoma". Histological progression or composite malignancy?

Authors:  J T Sundeen; J Cossman; E S Jaffe
Journal:  Am J Surg Pathol       Date:  1988-08       Impact factor: 6.394

2.  The use of proteolytic enzymes to improve immunoglobulin staining by the PAP technique.

Authors:  B L Mepham; W Frater; B S Mitchell
Journal:  Histochem J       Date:  1979-05

3.  Absence of B-cell or T-cell clonal expansion in nodular, lymphocyte predominant Hodgkin's disease.

Authors:  M D Linden; A J Fishleder; W E Katzin; R R Tubbs
Journal:  Hum Pathol       Date:  1988-05       Impact factor: 3.466

4.  Differential diagnostic features of nodular L & H Hodgkin's disease, including progressive transformation of germinal centers.

Authors:  B F Burns; T V Colby; R F Dorfman
Journal:  Am J Surg Pathol       Date:  1984-04       Impact factor: 6.394

5.  Follicular bronchitis/bronchiolitis.

Authors:  S A Yousem; T V Colby; C B Carrington
Journal:  Hum Pathol       Date:  1985-07       Impact factor: 3.466

6.  Immunohistologic analysis of the organization of normal lymphoid tissue and non-Hodgkin's lymphomas.

Authors:  H Stein; A Bonk; G Tolksdorf; K Lennert; H Rodt; J Gerdes
Journal:  J Histochem Cytochem       Date:  1980-08       Impact factor: 2.479

7.  Hodgkin's disease, lymphocyte predominance type, nodular--a distinct entity? Unique staining profile for L&H variants of Reed-Sternberg cells defined by monoclonal antibodies to leukocyte common antigen, granulocyte-specific antigen, and B-cell-specific antigen.

Authors:  G S Pinkus; J W Said
Journal:  Am J Pathol       Date:  1985-01       Impact factor: 4.307

8.  Nodular paragranuloma and progressively transformed germinal centers. Ultrastructural and immunohistologic findings.

Authors:  S Poppema; E Kaiserling; K Lennert
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1979

9.  Polyclonal polymorphic B-cell lymphoproliferative disorder with prominent pulmonary involvement in children with acquired immune deficiency syndrome.

Authors:  V V Joshi; S Kauffman; J M Oleske; S Fikrig; T Denny; C Gadol; E Lee
Journal:  Cancer       Date:  1987-04-15       Impact factor: 6.860

10.  Clinical features of nodular paragranuloma (Hodgkin's disease, lymphocyte predominance type, nodular).

Authors:  M L Hansmann; T Zwingers; A Böske; H Löffler; K Lennert
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

View more
  3 in total

1.  L and H cells of nodular lymphocyte predominant Hodgkin's disease show immunoglobulin light-chain restriction.

Authors:  C Schmid; C Sargent; P G Isaacson
Journal:  Am J Pathol       Date:  1991-12       Impact factor: 4.307

2.  Hodgkin's disease and common variable immunodeficiency.

Authors:  T Zenone
Journal:  J Clin Pathol       Date:  1996-12       Impact factor: 3.411

3.  Small intestinal presentation of nodular lymphocyte-predominant Hodgkin lymphoma with T cell/histiocyte-rich B cell lymphoma-like areas-with review of literature on extranodal presentation of this disease.

Authors:  Izhar N Bagwan; Graham Knee; Zaid Abboudi; Kikkeri N Naresh
Journal:  J Hematop       Date:  2010-03-24       Impact factor: 0.196

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.